A portion of the work described herein was carried out by Jennifer Kasper in partial fulfilment of the requirements for a biological doctoral degree at the Johannes Gutenberg University, Mainz, Germany. The authors wish to thank Ms. Elke Hübsch and Ms Michaela Moisch for their excellent assistance with the cell culture and immunocytochemical

studies. This study was supported by the DFG priority program SPP 1313 within the Cluster BIONEERS and also by the European Union, FP6 Project NanoBioPharmaceutics. “
“The applications of microparticles and nanoparticles Ibrutinib ic50 as delivery vehicles or therapeutic entities are widely described in the literature. Their combination, for example, as nanoparticle-in-microparticle (NIM) systems, offers the possibility of dual or multiple functionalities within a formulation. For example, multiple release profiles (burst release from outer particles selleck chemical and sustained release from internal components) and/or combinations of features allowing site

specificity, in vivo protection, cellular interactions, imaging capabilities and embolisation can all be envisaged. In recent examples, Veiseh et al. proposed multifunctional delivery systems comprising both imaging and therapeutic agents, in addition to a functionalised surface to enhance specific cell interactions [1]. Pouponneau et al. produced a microparticle system that encapsulated magnetic Ketanserin nanoparticles and showed that under the influence of a magnetic field, the particles could be steered in vitro [2]. Another example includes theophylline-loaded NIM suitable for asthmatic treatment in which Jelvehgari et al. utilised the outer microparticle as a means to reduce burst release [3]. Various methods have been proposed for the preparation of NIM systems. Spray drying techniques have been used to produce NIMs for aerosols [4], [5], [6] and [7], oral [8] and [9] and intravitreal

formulations [10]. Other methods include supercritical fluid techniques [11], [12] and [13]. There is, however, little information on how NIMs can be produced using the standard emulsion techniques that are widely and conveniently used in the preparation of particles for drug delivery research. Such methods for preparing single-component particles (i.e. microparticles or nanoparticles alone) are renowned for their application to both hydrophilic or hydrophobic drugs and a variety of polymer systems [14]. Additionally, through modification of process parameters, characteristics such as particle size distribution and morphology can be readily altered. While work such as Jelvehgari et al. [3] provides methodology for NIM formation, there is little convincing information in the drug delivery literature on the internal structure of NIMs or the distribution of nanoparticles therein.